비교리스트

 카트 문의
시장보고서
상품코드
1424065

마이코플라스마 검사 시장 점유율, 규모, 동향, 산업 분석 보고서 : 제품 및 서비스별, 기술별, 용도별, 최종사용자별, 지역별, 부문별 예측(2024-2032년)

Mycoplasma Testing Market Share, Size, Trends, Industry Analysis Report, By Product & Service (Assays, Kits, & Reagents, Instruments, Services); By Technique; By Application; By End User; By Region; Segment Forecast, 2024 - 2032
발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 118 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면, 세계 마이코플라스마 검사 시장 규모는 2032년까지 29억 964만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.

마이코플라스마는 세포벽이 없는 세균의 일종입니다. 주로 인간의 호흡기, 비뇨기 및 생식기를 감염시킬 가능성이 높습니다. 엄격한 규제가 존재하고 소비자 안전에 대한 우려가 높아짐에 따라 제약 회사는 마이코플라스마 검사를 포함한 종합적인 생물학적 검사에 주력하고 있습니다.

2023년 Journal of Microbiology에 게재된 연구는 마이코플라스마 제니탈륨 검출의 진전을 모색하는 데 초점을 맞추고 있습니다. 최근 미국 식품의약국(FDA)이 분자 기반 분석법을 승인함에 따라 진단 테스트가 미국에서 널리 채택되어 더 이상 일부 실험실에서만 사용할 수 없게 되었습니다. 이는 마이코플라스마 시장 성장에 긍정적인 영향을 미치고 있습니다.

항균제 내성의 출현은 의약품과 서비스에서 마이코플라스마의 존재를 검사하는 것을 어렵게 만들었고, 이는 내성을 판단하는 진단 테스트의 개발에 박차를 가했습니다. 마이코플라스마는 연구 단계부터 임상 개발까지 바이오의약품의 제조 단계에서 대부분 검출되어 특정 질병 치료의 안전성과 정확성을 확인하기 위해 마이코플라스마 검사의 필요성을 강조하고 있습니다.

이 분야의 연구 혁신의 발전과 첨단 기술의 채택은 마이코플라스마 검사 시장의 확장을 촉진할 것으로 예상됩니다. 예를 들어, 2023년 11월 QIAGEN은 세포 및 유전자 치료, 식품 산업 및 제약 산업에서 중합효소 연쇄반응 기술 제품 라인을 확장하기 위해 3개의 새로운 QIAcuity 키트와 소프트웨어 업데이트를 발표했습니다.

제품의 품질과 안전성을 높이기 위한 바이오 제약사들의 지속적인 확장 활동은 마이코플라스마 검사 시장에 긍정적인 영향을 미치고 있습니다. 예를 들어, 2023년 11월, 박테리아로부터 의약품을 보호하는 전문 제약 연구소인 바이오니크(Bionique)는 이 지역에서 빠르게 성장하고 있는 세포 및 유전자 치료의 지속적인 수요에 대응하기 위해 뉴욕주 레이크 클리어(Lake Clear, NY)에 거점을 확장했습니다.

마이코플라스마 검사 시장 보고서 하이라이트

분석, 키트 및 시약 부문은 즉시 검사할 수 있는 키트의 필요성으로 인해 향후 몇 년 동안 가장 높은 성장세를 보일 것으로 예상됩니다.

시장 세분화 부문은 신속한 검사 결과를 제공할 수 있기 때문에 가장 큰 시장 점유율을 차지하고 있습니다.

세포주 검사 부문은 바이오의약품 생산 증가로 인해 더 큰 매출 비중을 차지할 것으로 예상됩니다.

아시아태평양은 세포치료 및 유전자 치료 분야의 기술 혁신이 증가함에 따라 예측 기간 동안 가장 빠른 성장을 기록할 것으로 예상됩니다.

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 세계의 마이코플라스마 검사 시장에 관한 인사이트

  • 마이코플라스마 검사 - 업계 현황
  • 마이코플라스마 검사 시장 역학
    • 성장 촉진요인과 기회
      • 마이코플라스마 검출을 찾는 조사가 증가
      • 마이코플라스마 관련 건강 문제 발생률 증가
    • 성장 억제요인과 과제
      • 새로운 혁신을 채용할 때 연구자 저항
  • PESTLE 분석
  • 마이코플라스마 검사 업계 동향
  • 밸류체인 분석
  • COVID-19 감염증의 영향 분석

제5장 세계의 마이코플라스마 검사 시장, 제품 및 서비스별

  • 주요 조사 결과
  • 서론
  • 어세이, 키트, 시약
  • 기기
  • 서비스

제6장 세계의 마이코플라스마 검사 시장, 용도별

  • 주요 조사 결과
  • 서론
  • 세포주 검사
  • 바이러스 검사
  • 생산 종료후 세포 검사

제7장 세계의 마이코플라스마 검사 시장, 기술별

  • 주요 조사 결과
  • 서론
  • NAT
  • ELISA
  • 염색
  • 기타 기술

제8장 세계의 마이코플라스마 검사 시장, 최종사용자별

  • 주요 조사 결과
  • 서론
  • 제약·바이오테크놀러지 기업
  • 세포은행과 연구소
  • 수탁연구기관
  • 학술연구기관

제9장 세계의 마이코플라스마 검사 시장, 지역별

  • 주요 조사 결과
  • 서론
    • 마이코플라스마 검사 시장 평가, 지역별, 2019-2032년
  • 마이코플라스마 검사 시장 - 북미
    • 북미 : 마이코플라스마 검사 시장, 제품 및 서비스별, 2019-2032년
    • 북미 : 마이코플라스마 검사 시장, 최종사용자별, 2019-2032년
    • 북미 : 마이코플라스마 검사 시장, 용도별, 2019-2032년
    • 북미 : 마이코플라스마 검사 시장, 기술별, 2019-2032년
    • 마이코플라스마 검사 시장 - 미국
    • 마이코플라스마 검사 시장 - 캐나다
  • 마이코플라스마 검사 시장 - 유럽
    • 유럽 : 마이코플라스마 검사 시장, 제품 및 서비스별, 2019-2032년
    • 유럽 : 마이코플라스마 검사 시장, 최종사용자별, 2019-2032년
    • 유럽 : 마이코플라스마 검사 시장, 용도별, 2019-2032년
    • 유럽 : 마이코플라스마 검사 시장, 기술별, 2019-2032년
    • 마이코플라스마 검사 시장 - 영국
    • 마이코플라스마 검사 시장 - 프랑스
    • 마이코플라스마 검사 시장 - 독일
    • 마이코플라스마 검사 시장 - 이탈리아
    • 마이코플라스마 검사 시장 - 스페인
    • 마이코플라스마 검사 시장 - 네덜란드
    • 마이코플라스마 검사 시장 - 러시아
  • 마이코플라스마 검사 시장 - 아시아태평양
    • 아시아태평양 : 마이코플라스마 검사 시장, 제품 및 서비스별, 2019-2032년
    • 아시아태평양 : 마이코플라스마 검사 시장, 최종사용자별, 2019-2032년
    • 아시아태평양 : 마이코플라스마 검사 시장, 용도별, 2019-2032년
    • 아시아태평양 : 마이코플라스마 검사 시장, 기술별, 2019-2032년
    • 마이코플라스마 검사 시장 - 중국
    • 마이코플라스마 검사 시장 - 인도
    • 마이코플라스마 검사 시장 - 일본
    • 마이코플라스마 검사 시장 - 말레이시아
    • 마이코플라스마 검사 시장 - 인도네시아
    • 마이코플라스마 검사 시장 - 한국
  • 마이코플라스마 검사 시장 - 중동 및 아프리카
    • 중동 및 아프리카 : 마이코플라스마 검사 시장, 제품 및 서비스별, 2019-2032년
    • 중동 및 아프리카 : 마이코플라스마 검사 시장, 최종사용자별, 2019-2032년
    • 중동 및 아프리카 : 마이코플라스마 검사 시장, 용도별, 2019-2032년
    • 중동 및 아프리카 : 마이코플라스마 검사 시장, 기술별, 2019-2032년
    • 마이코플라스마 검사 시장 - 사우디아라비아
    • 마이코플라스마 검사 시장 - 남아프리카공화국
    • 마이코플라스마 검사 시장 - 이스라엘
    • 마이코플라스마 검사 시장 - UAE
  • 마이코플라스마 검사 시장 - 라틴아메리카
    • 라틴아메리카 : 마이코플라스마 검사 시장, 제품 및 서비스별, 2019-2032년
    • 라틴아메리카 : 마이코플라스마 검사 시장, 최종사용자별, 2019-2032년
    • 라틴아메리카 : 마이코플라스마 검사 시장, 용도별, 2019-2032년
    • 라틴아메리카 : 마이코플라스마 검사 시장, 기술별, 2019-2032년
    • 마이코플라스마 검사 시장 - 멕시코
    • 마이코플라스마 검사 시장 - 브라질
    • 마이코플라스마 검사 시장 - 아르헨티나

제10장 경쟁 상황

  • 확장과 인수 분석
    • 확대
    • 인수
  • 제휴/협업/합의/공개

제11장 기업 개요

  • Agilent Technologies(US)
  • American Type Culture Collection(US)
  • Biological Industries Israel Beit Haemek Ltd.(Israel)
  • Bionique Testing Laboratories, Inc.(US)
  • Biotools B & M Labs, S.A.(Spain)
  • Charles River Laboratories International, Inc.(US)
  • Creative Bioarray(US)
  • Eurofins Scientific(Luxembourg)
  • GeneCopoeia, Inc.(US)
  • GenBio(Canada)
  • InvivoGen(US)
  • Lonza Group Ltd.(Switzerland)
  • Merck KGaA(Germany)
  • Meridian Bioscience, Inc.(US)
  • Minerva Biolabs GmbH(Germany)
ksm 24.02.23

The global mycoplasma testing market size is expected to reach USD 2909.64 Million by 2032, according to a new study by Polaris Market Research. The report "Mycoplasma Testing Market Share, Size, Trends, Industry Analysis Report, By Product & Service (Assays, Kits, & Reagents, Instruments, Services); By Technique; By Application; By End User; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Mycoplasma is a type of bacteria without a cell wall. It is mostly likely to affect the respiratory, urinary, and genital tracts of humans. The presence of stringent regulations and growing concerns about consumer safety is enabling pharmaceutical companies to focus on comprehensive biological testing, including testing of mycoplasma.

A 2023 study published in the Journal of Microbiology focused on exploring advancements in the detection of Mycoplasma genitalium. The recent clearance of molecular-based assays by the U.S. Food and Drug Administration (FDA) permitted diagnostic testing to be widely employed in the United States, making it no longer available only in some laboratories. This is positively influencing the growth of the mycoplasma market.

The emergence of antimicrobial resistance made it difficult to test the presence of mycoplasma in pharmaceutical products and services, which fueled the development of diagnostic tests to determine resistance. Mycoplasma is mostly found in the production phase of biopharmaceutical products, including from the research stage to clinical development, highlighting the need for mycoplasma testing to check safety and accuracy in treating certain diseases.

The growing research innovations in this field and the adoption of advanced technologies are anticipated to promote the expansion of the mycoplasma testing market. For instance, in November 2023, QIAGEN unveiled its three new QIAcuity kits and software update to expand its product line for polymerase chain reaction technology in cell and gene therapies, the food industry, and the pharmaceutical industry.

Ongoing expansion activities by biopharmaceutical companies to enhance the quality and safety of their products are positively influencing the mycoplasma testing market. For instance, in November 2023, Bionique, a pharmaceutical lab specializing in protecting medicines from bacteria, expanded its location at Lake Clear, New York, to meet ongoing demand from rapidly growing cell and gene therapies in the region.

Mycoplasma Testing Market Report Highlights

Assays, Kits, & reagents segment is anticipated to witness the highest growth in the coming years due to the need for ready-to-test kits.

NAT segment accounted for the largest market share owing to its capability to offer faster results.

Cell line testing segment is projected to experience a larger revenue share due to growing biopharmaceutical production.

Asia Pacific is projected to register the fastest growth during the forecast period, attributable to the rising innovations in cell and gene therapies.

The global players include Agilent Technologies, American Type Culture Collection, Biological Industries Israel Beit Haemek Ltd, & Bionique Testing Laboratories, Inc.

Polaris Market Research has segmented the mycoplasma testing market report based on product & service, technique, application, end user and region:

Mycoplasma Testing, Product & Service Outlook (Revenue - USD Million, 2019 - 2032)

  • Assays, Kits, & Reagents
  • NAT assays, kits, & reagents
  • ELISA assays, kits, & reagents
  • Elimination Kits
  • Stains
  • Other assays, kits, & reagents
  • Instruments
  • Services

Mycoplasma Testing, Technique Outlook (Revenue - USD Million, 2019 - 2032)

  • NAT
  • ELISA
  • Staining
  • Other technique

Mycoplasma Testing, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Cell line testing
  • Virus Testing
  • End-of-Production cell testing

Mycoplasma Testing, End User Outlook (Revenue - USD Million, 2019 - 2032)

  • Pharmaceutical & Biotechnology Companies
  • Cell Banks & Laboratories
  • Contract Research Organizations
  • Academic Research Institutes

Mycoplasma Testing, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Mycoplasma Testing Market Insights

  • 4.1. Mycoplasma Testing - Industry Snapshot
  • 4.2. Mycoplasma Testing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising research studies exploring mycoplasma detection
      • 4.2.1.2. The growing incidence of mycoplasma-related health issues
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. The researchers' resistance in adopting new innovations
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Mycoplasma Testing Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Mycoplasma Testing Market, by Product & Service

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • 5.3. Assays, Kits, & Reagents
    • 5.3.1. Global Mycoplasma Testing Market, by Assays, Kits, & Reagents, by Region, 2019-2032 (USD Million)
    • 5.3.2. NAT assays, kits, & reagents
      • 5.3.2.1. Global Mycoplasma Testing Market, by NAT assays, kits, & reagents, by Region, 2019-2032 (USD Million)
    • 5.3.3. ELISA assays, kits, & reagents
      • 5.3.3.1. Global Mycoplasma Testing Market, by ELISA assays, kits, & reagents, by Region, 2019-2032 (USD Million)
    • 5.3.4. Elimination Kits
      • 5.3.4.1. Global Mycoplasma Testing Market, by Elimination Kits, by Region, 2019-2032 (USD Million)
    • 5.3.5. Stains
      • 5.3.5.1. Global Mycoplasma Testing Market, by Stains, by Region, 2019-2032 (USD Million)
    • 5.3.6. Other assays, kits, & reagents
      • 5.3.6.1. Global Mycoplasma Testing Market, by Other assays, kits, & reagents, by Region, 2019-2032 (USD Million)
  • 5.4. Instruments
    • 5.4.1. Global Mycoplasma Testing Market, by Instruments, by Region, 2019-2032 (USD Million)
  • 5.5. Services
    • 5.5.1. Global Mycoplasma Testing Market, by Services, by Region, 2019-2032 (USD Million)

6. Global Mycoplasma Testing Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • 6.3. Cell line testing
    • 6.3.1. Global Mycoplasma Testing Market, by Cell line testing, by Region, 2019-2032 (USD Million)
  • 6.4. Virus Testing
    • 6.4.1. Global Mycoplasma Testing Market, by Virus Testing, by Region, 2019-2032 (USD Million)
  • 6.5. End-of-Production cell testing
    • 6.5.1. Global Mycoplasma Testing Market, by End-of-Production cell testing, by Region, 2019-2032 (USD Million)

7. Global Mycoplasma Testing Market, by Technique

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • 7.3. NAT
    • 7.3.1. Global Mycoplasma Testing Market, by NAT, by Region, 2019-2032 (USD Million)
  • 7.4. ELISA
    • 7.4.1. Global Mycoplasma Testing Market, by ELISA, by Region, 2019-2032 (USD Million)
  • 7.5. Staining
    • 7.5.1. Global Mycoplasma Testing Market, by Staining, by Region, 2019-2032 (USD Million)
  • 7.6. Other technique
    • 7.6.1. Global Mycoplasma Testing Market, by Other technique, by Region, 2019-2032 (USD Million)

8. Global Mycoplasma Testing Market, by End User

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • 8.3. Pharmaceutical & Biotechnology Companies
    • 8.3.1. Global Mycoplasma Testing Market, by Pharmaceutical & Biotechnology Companies, by Region, 2019-2032 (USD Million)
  • 8.4. Cell Banks & Laboratories
    • 8.4.1. Global Mycoplasma Testing Market, by Cell Banks & Laboratories, by Region, 2019-2032 (USD Million)
  • 8.5. Contract Research Organizations
    • 8.5.1. Global Mycoplasma Testing Market, by Contract Research Organizations, by Region, 2019-2032 (USD Million)
  • 8.6. Academic Research Institutes
    • 8.6.1. Global Mycoplasma Testing Market, by Academic Research Institutes, by Region, 2019-2032 (USD Million)

9. Global Mycoplasma Testing Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Mycoplasma Testing Market Assessment, By Geography, 2019-2032 (USD Million)
  • 9.3. Mycoplasma Testing Market - North America
    • 9.3.1. North America: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
    • 9.3.2. North America: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
    • 9.3.3. North America: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
    • 9.3.4. North America: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.3.5. Mycoplasma Testing Market - U.S.
      • 9.3.5.1. U.S.: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.3.5.2. U.S.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.3.5.3. U.S.: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.3.5.4. U.S.: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.3.6. Mycoplasma Testing Market - Canada
      • 9.3.6.1. Canada: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.3.6.2. Canada: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.3.6.3. Canada: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.3.6.4. Canada: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • 9.4. Mycoplasma Testing Market - Europe
    • 9.4.1. Europe: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
    • 9.4.2. Europe: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
    • 9.4.3. Europe: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
    • 9.4.4. Europe: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.4.5. Mycoplasma Testing Market - UK
      • 9.4.5.1. UK: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.5.2. UK: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.4.5.3. UK: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.4.5.4. UK: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.4.6. Mycoplasma Testing Market - France
      • 9.4.6.1. France: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.6.2. France: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.4.6.3. France: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.4.6.4. France: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.4.7. Mycoplasma Testing Market - Germany
      • 9.4.7.1. Germany: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.7.2. Germany: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.4.7.3. Germany: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.4.7.4. Germany: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.4.8. Mycoplasma Testing Market - Italy
      • 9.4.8.1. Italy: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.8.2. Italy: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.4.8.3. Italy: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.4.8.4. Italy: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.4.9. Mycoplasma Testing Market - Spain
      • 9.4.9.1. Spain: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.9.2. Spain: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.4.9.3. Spain: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.4.9.4. Spain: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.4.10. Mycoplasma Testing Market - Netherlands
      • 9.4.10.1. Netherlands: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.10.2. Netherlands: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.4.10.3. Netherlands: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.4.10.4. Netherlands: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.4.11. Mycoplasma Testing Market - Russia
      • 9.4.11.1. Russia: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.11.2. Russia.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.4.11.3. Russia: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.4.11.4. Russia: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • 9.5. Mycoplasma Testing Market - Asia Pacific
    • 9.5.1. Asia Pacific: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
    • 9.5.2. Asia Pacific: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
    • 9.5.3. Asia Pacific: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
    • 9.5.4. Asia Pacific: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.5.5. Mycoplasma Testing Market - China
      • 9.5.5.1. China: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.5.2. China.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.5.5.3. China: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.5.5.4. China: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.5.6. Mycoplasma Testing Market - India
      • 9.5.6.1. India: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.6.2. India.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.5.6.3. India: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.5.6.4. India: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.5.7. Mycoplasma Testing Market - Japan
      • 9.5.7.1. Japan: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.7.2. Japan.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.5.7.3. Japan: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.5.7.4. Japan: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.5.8. Mycoplasma Testing Market - Malaysia
      • 9.5.8.1. Malaysia: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.8.2. Malaysia.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.5.8.3. Malaysia: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.5.8.4. Malaysia: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.5.9. Mycoplasma Testing Market - Indonesia
      • 9.5.9.1. Indonesia: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.9.2. Indonesia.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.5.9.3. Indonesia: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.5.9.4. Indonesia: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.5.10. Mycoplasma Testing Market - South Korea
      • 9.5.10.1. South Korea: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.10.2. South Korea.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.5.10.3. South Korea: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.5.10.4. South Korea: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • 9.6. Mycoplasma Testing Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
    • 9.6.2. Middle East & Africa: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
    • 9.6.3. Middle East & Africa: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
    • 9.6.4. Middle East & Africa: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.6.5. Mycoplasma Testing Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.6.5.2. Saudi Arabia: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.6.5.3. Saudi Arabia: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.6.5.4. Saudi Arabia: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.6.6. Mycoplasma Testing Market - South Africa
      • 9.6.6.1. South Africa: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.6.6.2. South Africa: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.6.6.3. South Africa: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.6.6.4. South Africa: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.6.7. Mycoplasma Testing Market - Israel
      • 9.6.7.1. Israel: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.6.7.2. Israel: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.6.7.3. Israel: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.6.7.4. Israel: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.6.8. Mycoplasma Testing Market - UAE
      • 9.6.8.1. UAE: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.6.8.2. UAE: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.6.8.3. UAE: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.6.8.4. UAE: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • 9.7. Mycoplasma Testing Market - Latin America
    • 9.7.1. Latin America: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
    • 9.7.2. Latin America: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
    • 9.7.3. Latin America: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
    • 9.7.4. Latin America: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.7.5. Mycoplasma Testing Market - Mexico
      • 9.7.5.1. Mexico: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.7.5.2. Mexico: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.7.5.3. Mexico: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.7.5.4. Mexico: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.7.6. Mycoplasma Testing Market - Brazil
      • 9.7.6.1. Brazil: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.7.6.2. Brazil: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.7.6.3. Brazil: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.7.6.4. Brazil: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.7.7. Mycoplasma Testing Market - Argentina
      • 9.7.7.1. Argentina: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.7.7.2. Argentina: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.7.7.3. Argentina: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.7.7.4. Argentina: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Agilent Technologies (US)
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. American Type Culture Collection (US)
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Biological Industries Israel Beit Haemek Ltd. (Israel)
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Bionique Testing Laboratories, Inc. (US)
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Biotools B & M Labs, S.A. (Spain)
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Charles River Laboratories International, Inc. (US)
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Creative Bioarray (US)
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Eurofins Scientific (Luxembourg)
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. GeneCopoeia, Inc. (US)
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. GenBio (Canada)
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. InvivoGen (US)
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Lonza Group Ltd. (Switzerland)
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Merck KGaA (Germany)
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Meridian Bioscience, Inc. (US)
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. Minerva Biolabs GmbH (Germany)
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제